Viral
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals.
Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, Jeang KT.
Retrovirology. 2008 Dec 29;5:118.
Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication.
Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V, Lalwani M, Pillai B, Mitra D, Brahmachari SK.
Retrovirology. 2008 Dec 23;5:117.
Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, Flemington EK.
Virology. 2008 Dec 20;382(2):257-66.
microRNA-122 stimulates translation of hepatitis C virus RNA.
Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, Jünemann C, Niepmann M.
EMBO J. 2008 Dec 17;27(24):3300-10.
Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in
B lymphoma cell lines.
Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K.
Biochem Biophys Res Commun. 2008 Dec 12;377(2):579-83.
MicroRNAs of Kaposi's sarcoma-associated herpes virus.
Ganem D, Ziegelbauer J.
Semin Cancer Biol. 2008 Dec;18(6):437-40.
Regulation of hepatitis C virus by microRNA-122.
Jopling CL.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1220-3.
MicroRNAs fine-tune oncolytic viruses.
Bell JC, Kirn D.
Nat Biotechnol. 2008 Dec;26(12):1346-8.
Sequence conservation and differential expression of Marek's disease virus microRNAs.
Morgan R, Anderson A, Bernberg E, Kamboj S, Huang E, Lagasse G, Isaacs G, Parcells M, Meyers BC, Green PJ, Burnside J.
J Virol. 2008 Dec;82(24):12213-20.
Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in
a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response.
Dang LT, Kondo H, Aoki T, Hirono I.
Antiviral Res. 2008 Dec;80(3):316-23.
Analysis of BART7 microRNA from Epstein-Barr virus-infected nasopharyngeal carcinoma cells by capillary electrophoresis.
Chang PL, Chang YS, Chen JH, Chen SJ, Chen HC.
Anal Chem. 2008 Nov 15;80(22):8554-60.
Epstein-Barr virus-mediated dysregulation of human microRNA expression.
Godshalk SE, Bhaduri-McIntosh S, Slack FJ.
Cell Cycle. 2008 Nov 15;7(22):3595-600.
MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.
Pichler K, Schneider G, Grassmann R.
Retrovirology. 2008 Nov 12;5:100.
How HTLV-1 may subvert miRNAs for persistence and transformation.
Bouzar AB, Willems L.
Retrovirology. 2008 Nov 12;5:101.
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation
by human T-cell lymphotrophic virus 1.
Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT.
Cancer Res. 2008 Nov 1;68(21):8976-85.
The roles of microRNAs in mammalian virus infection.
Grassmann R, Jeang KT.
Biochim Biophys Acta. 2008 Nov;1779(11):706-11.
Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M.
Nucleic Acids Res. 2008 Nov;36(20):6608-19.
Engineering microRNA responsiveness to decrease virus pathogenicity.
Kelly EJ, Hadac EM, Greiner S, Russell SJ.
Nat Med. 2008 Nov;14(11):1278-83.
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.
Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K.
J Virol. 2008 Nov;82(22):11009-15.
[RNA interference as antiviral strategy]
Neumann-Haefelin C, Blum HE, Thimme R.
Dtsch Med Wochenschr. 2008 Nov;133(46):2407-9.
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival.
Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY.
J Exp Med. 2008 Oct 27;205(11):2551-60.
Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation
phenotype in mice.
Jin L, Carpenter D, Moerdyk-Schauwecker M, Vanarsdall AL, Osorio N, Hsiang C, Jones C, Wechsler SL.
J Neurovirol. 2008 Oct;14(5):389-400.
Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts.
Snyder LL, Esser JM, Pachuk CJ, Steel LF.
Antiviral Res. 2008 Oct;80(1):36-44.
Retrovirus-induced oncogenesis and safety of retroviral vectors.
Nair V.
Curr Opin Mol Ther. 2008 Oct;10(5):431-8.
Evolutionarily conserved function of a viral microRNA.
Seo GJ, Fink LH, O'Hara B, Atwood WJ, Sullivan CS.
J Virol. 2008 Oct;82(20):9823-8.
Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.
Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA.
J Virol. 2008 Oct;82(20):9964-77.
RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus.
Ludwig LB.
Retrovirology. 2008 Sep 11;5:79.
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.
Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R.
Cell Host Microbe. 2008 Sep 11;4(3):239-48.
Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication.
Wang FZ, Weber F, Croce C, Liu CG, Liao X, Pellett PE.
J Virol. 2008 Sep;82(18):9065-74.
Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.
Edwards RH, Marquitz AR, Raab-Traub N.
J Virol. 2008 Sep;82(18):9094-106.
An insect virus-encoded microRNA regulates viral replication.
Hussain M, Taft RJ, Asgari S.
J Virol. 2008 Sep;82(18):9164-70.
Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a.
Eletto D, Russo G, Passiatore G, Del Valle L, Giordano A, Khalili K, Gualco E, Peruzzi F.
J Cell Physiol. 2008 Sep;216(3):764-70.
Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL.
World J Gastroenterol. 2008 Aug 7;14(29):4684-9.
MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.
Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR.
Nature. 2008 Aug 7;454(7205):780-3.
An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor.
Tang S, Bertke AS, Patel A, Wang K, Cohen JI, Krause PR.
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10931-6.
Inhibition of Marek's disease virus replication by retroviral vector-based RNA interference.
Chen M, Payne WS, Hunt H, Zhang H, Holmen SL, Dodgson JB.
Virology. 2008 Aug 1;377(2):265-72.
Virus meets RNAi. Symposium on antiviral applications of RNA interference.
van Rij RP.
EMBO Rep. 2008 Aug;9(8):725-9.
Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells.
Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM.
J Virol. 2008 Aug;82(16):8215-23.
Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1).
Kumar A, Jeang KT.
J Cell Physiol. 2008 Aug;216(2):327-31.
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome.
Jopling CL, Schütz S, Sarnow P.
Cell Host Microbe. 2008 Jul 17;4(1):77-85.
Small RNAs in viral infection and host defense.
Mlotshwa S, Pruss GJ, Vance V.
Trends Plant Sci. 2008 Jul;13(7):375-82.
Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.
Gottwein E, Cullen BR.
Cell Host Microbe. 2008 Jun 12;3(6):375-87.
Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma.
Jun SM, Hong YS, Seo JS, Ko YH, Yang CW, Lee SK.
Br J Haematol. 2008 Jun;142(2):320-3.
Viruses and RNA silencing.
Mine A, Okuno T.
Uirusu. 2008 Jun;58(1):61-8.
The functions of herpesvirus-encoded microRNAs.
Grey F, Hook L, Nelson J.
Med Microbiol Immunol. 2008 Jun;197(2):261-7.
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways.
Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK.
J Virol. 2008 Jun;82(11):5295-306.
A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses.
Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, Aggarwal M, Mahalingam K, Bagasra O.
Biochem Biophys Res Commun. 2008 May 2;369(2):357-62.
HPV-16 RNA processing.
Schwartz S.
Front Biosci. 2008 May 1;13:5880-91.
Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron.
Liu YP, Haasnoot J, ter Brake O, Berkhout B, Konstantinova P.
Nucleic Acids Res. 2008 May;36(9):2811-24.
Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR.
Xu H, Yao Y, Zhao Y, Smith LP, Baigent SJ, Nair V.
J Virol Methods. 2008 May;149(2):201-8.
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA.
Oncogene. 2008 Apr 17;27(18):2575-82.
Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency.
Murphy E, Vanícek J, Robins H, Shenk T, Levine AJ.
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5453-8.
Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element.
Ouellet DL, Plante I, Landry P, Barat C, Janelle ME, Flamand L, Tremblay MJ, Provost P.
Nucleic Acids Res. 2008 Apr;36(7):2353-65.
MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.
Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, Watson M, Nair V.
J Virol. 2008 Apr;82(8):4007-15.
Modulation of natural killer cells by human cytomegalovirus.
Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, McSharry BP, Rickards CR, Cochrane D,
Llewellyn-Lacey S, Wang EC, Griffin CA, Davison AJ.
J Clin Virol. 2008 Mar;41(3):206-12.
Identification and function of human cytomegalovirus microRNAs.
Grey F, Nelson J.
J Clin Virol. 2008 Mar;41(3):186-91.
RNA interference: a multifaceted innate antiviral defense.
Kumar A.
Retrovirology. 2008 Feb 1;5:17.
Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.
Westmoreland SV, Mansfield KG.
Comp Med. 2008 Feb;58(1):31-42.
Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK.
J Virol. 2008 Feb;82(4):1946-58.
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5.
Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jäker C, Höck J, Meister G, Grässer FA.
Nucleic Acids Res. 2008 Feb;36(2):666-75.
Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network.
McClure LV, Sullivan CS.
Cell Host Microbe. 2008 Jan 17;3(1):1-3.
A balancing act: viruses and miRNAs.
Berkhout B.
J Formos Med Assoc. 2008 Jan;107(1):1-3.
Vir-Mir db: prediction of viral microRNA candidate hairpins.
Li SC, Shiau CK, Lin WC.
Nucleic Acids Res. 2008 Jan;36(Database issue):D184-9.
The properties and functions of virus encoded microRNA, siRNA, and other small noncoding RNAs.
He S, Yang Z, Skogerbo G, Ren F, Cui H, Zhao H, Chen R, Zhao Y.
Crit Rev Microbiol. 2008;34(3-4):175-88.
Human cytomegalovirus microRNAs.
Fannin Rider PJ, Dunn W, Yang E, Liu F.
Curr Top Microbiol Immunol. 2008;325:21-39.